adenosine monophosphate has been researched along with Inflammatory Response Syndrome, Systemic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 8 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bannister, R; Bavari, S; Cihlar, T; Donnelly, G; Garza, NL; Gomba, L; Iversen, PL; Kane, CD; Norris, S; Porter, DP; Steffens, J; Stuthman, KS; Van Tongeren, SA; Warren, TK; Weidner, JM; Wells, J; Zeng, X | 1 |
| Zachariah, P | 1 |
| Chang, HT; Glaberson, WR; Leeman, R; Mahajan, N; Manalo, R | 1 |
| Abzug, MJ; Aldrich, ML; Bio, L; Chiotos, K; Cross, SJ; Denison, MR; Dillman, NO; Downes, KJ; Dulek, DE; Goldman, DL; Grapentine, S; Groves, HE; Hayes, M; Hersh, AL; James, SH; Jones, SB; Kimberlin, DW; Lamb, GS; MacBrayne, CE; Nakamura, MM; Newland, JG; Oliveira, CR; Olivero, R; Orscheln, RC; Pinninti, SG; Rajapakse, NS; Ratner, AJ; Schwenk, HT; Soma, VL; Tamma, PD; Thorell, EA; Timberlake, K; Tribble, AC; Vora, SB; Waghmare, A; Wattier, RL; Wolf, J; Yarbrough, A; Young, J; Zachariah, P | 1 |
| Eilenberger, J; Fischer, M; Haas, N; Hauck, F; Hermann, M; Huebner, J; Jakob, A; Kappler, M; Kim-Hellmuth, S; Klein, C; Ley-Zaporozhan, J; von Both, U | 1 |
| Clement, KC; Isani, M; Kihlstrom, M; McLean, SE; Phillips, MR; Schwartz, SP; Smith, MM; Smith, RL; Walker, TC | 1 |
| Hanseus, K; Heying, R; Michel-Behnke, I; Milanesi, O; Sendzikaite, S | 1 |
| Bayrakci, B; Cengiz, AB; Gülhan, B; Gürlevik, SL; Kesici, S; Kurt Sukur, ED; Oygar, PD; Ozen, S; Ozsurekci, Y; Topaloglu, R | 1 |
1 review(s) available for adenosine monophosphate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
COVID-19 in Children.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Child; COVID-19; Glucocorticoids; Hospitalization; Humans; Immunoglobulins, Intravenous; Systemic Inflammatory Response Syndrome | 2022 |
1 trial(s) available for adenosine monophosphate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
Topics: Acute Kidney Injury; Adenosine Monophosphate; Adolescent; Alanine; Amides; Child; COVID-19; COVID-19 Drug Treatment; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Male; Pyrazines; Renal Elimination; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2021 |
6 other study(ies) available for adenosine monophosphate and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.
Topics: Adenosine Monophosphate; Administration, Intravenous; Aerosols; Alanine; Animals; Antiviral Agents; Disease Models, Animal; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Kaplan-Meier Estimate; Liver; Lung; Lymph Nodes; Macaca mulatta; Male; Random Allocation; Systemic Inflammatory Response Syndrome; Viral Load; Viremia | 2021 |
Case of multisystem inflammatory syndrome in children presenting as fever and abdominal pain.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; C-Reactive Protein; Child; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; COVID-19 Serological Testing; Diagnosis, Differential; Fever; Humans; Interleukin 1 Receptor Antagonist Protein; Intubation, Intratracheal; Male; Mucocutaneous Lymph Node Syndrome; Myocarditis; Nasopharynx; Natriuretic Peptide, Brain; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachycardia; Treatment Outcome | 2020 |
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child; COVID-19; COVID-19 Drug Treatment; Evidence-Based Medicine; Humans; Immunocompromised Host; Risk Factors; Severity of Illness Index; Systemic Inflammatory Response Syndrome | 2021 |
SARS-CoV-2 Triggering Severe Acute Respiratory Distress Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in a 3-Year-Old Child With Down Syndrome.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Critical Care; Down Syndrome; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lymphohistiocytosis, Hemophagocytic; Male; Prednisolone; SARS-CoV-2; Systemic Inflammatory Response Syndrome | 2021 |
Extracorporeal Membrane Oxygenation for COVID-19-Associated Multisystem Inflammatory Syndrome in a 5-year-old.
Topics: Adenosine Monophosphate; Adrenergic alpha-Agonists; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Child, Preschool; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Epinephrine; Extracorporeal Membrane Oxygenation; Female; Humans; Hypotension; Immunization, Passive; Immunoglobulins, Intravenous; Interleukin 1 Receptor Antagonist Protein; Methylprednisolone; Norepinephrine; Shock, Cardiogenic; Systemic Inflammatory Response Syndrome | 2022 |
COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper.
Topics: Adenosine Monophosphate; Alanine; Anti-Arrhythmia Agents; Anticoagulants; Antiviral Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Surgical Procedures; Cardiology; COVID-19; COVID-19 Drug Treatment; Heart Defects, Congenital; Heart Transplantation; Humans; Immunologic Factors; Infectious Disease Transmission, Vertical; Long QT Syndrome; Myocarditis; Myocardium; Pediatrics; Risk Assessment; SARS-CoV-2; Societies, Medical; Systemic Inflammatory Response Syndrome; Tachycardia, Ventricular | 2021 |